Henagliflozin, a popular drug prescribed for type 2 diabetes, has demonstrated potential anti-aging effects in a recent study published in Cell Reports Medicine. Subscribe to our newsletter for the ...

Type 2 diabetes and the risks of cancer. The picture illustrates the association between diabetes and the risk of developing specific types of cancer, indicated by the presence of an upward arrow (↑) ...

Common diabetes drugs may do more than regulate blood sugar—they could also influence how cancers grow, spread, or slow down. Researchers are now unraveling how these medications affect immune ...

Diabetes, particularly Type 2 Diabetes (T2DM), has been linked to an increased risk of various cancers, including liver, colorectal, and breast cancer. While glycemic control and weight management are ...

Researchers at the Case Western Reserve School of Medicine have found that semaglutide, a popular diabetes and weight-loss drug, may lower the risk of dementia in people with type 2 diabetes (T2D).

Dr Reddy’s Laboratories has received final approval from India’s drug regulator to launch a generic version of oral semaglutide, marking its entry in the fast‑growing GLP‑1 diabetes and obesity drug ...

BIDMC-led study finds that adults with type 2 diabetes who use GLP1 drugs are less likely to develop peptic ulcer disease ...

UAB researchers have launched DiaClue, a free web-based tool that helps clinicians classify diabetes into five subtypes, ...